Efficacy of application of the luteotropic drug for the prevention of intrauterine growth restriction in dairy cows

Purpose: studying the effectiveness of the use of luteotropic action for preventing embryonic development disorders.Materials and methods. The research object is lactating animals in 60-75 days after a selection that manifests sex cyclicity and separated into 4 groups. The first group (n = 11) – in the insemination of parenterally injected the preparation of tautin at a dose of 5 ml. The second group (n = 11) – tautin was administered at a dose of 10 ml on the same time as cows of the first group. The third group (n = 12) – tautin injected 10 ml twice: during seeding and on the 14th day after seeding. The fourth group (n = 12) – was injected with saline per day of seeding and on the 14th day at a dose of 10 ml (negative control). Conducted a transrectal and ultrasound study at the end of the 1st and 2nd month of gestation, in which the size of the yellow body of pregnancy, embryo and the fetus was taken into account. Upon completion of pregnancy, all animals are taken into account: the nature of the flow of labor (physiological flow, objectiveness, fulbirth, detention, postpartum), postpartum period (physiological flow, submissiveness of the uterus, endometritis), the state of newborn calves (gender of the fetus, the time of manifestation of confident poses of standing, sucking reflex, body mass).Results. It has been established that the twofold administration of the tautin during seeding and on the 14th day after a dose of 10,0 ml is accompanied by an increase in fertilization by 19,7-28,8%, a decrease in the delay syndrome of the fetus development of 1,4-4,0 times, Absence of embryonic mortality. The use of the drug Tautin twice in a dose of 10,0 ml is accompanied by an increase in the size of the yellow body of pregnancy in 1,43-2,15 times, in comparison with other modes of its use, cockerel-dump-sized – by 12,9-37,6% and diameter Cases – by 10,1-46,6%. The use of a luteotropic drug is accompanied by a decrease in the incidence of cows to the detention of the last 1,8 times, the submissive of the uterus – 1,8 times, endometritis – by 2,7 times, the time of manifestation of confident posture of the standing of newborns of newborn calves – by 15,6 minutes, a sucking reflex – on 16,5 min and diarrheal syndrome – 2,7 times.Conclusion. The scientific novelty of research lies in the fact that new knowledge is obtained on the effectiveness of the use of the drug of luteotropic action, created using the technology of recombinant proteins, for the prevention of violations of embryonic development in cows.

Optimizing pressure-driven pulsatile flows in microfluidic devices

Unsteady and pulsatile flows receive increasing attention due to their potential to enhance various microscale processes. Further, they possess significant relevance for microfluidic studies under physiological flow conditions. However, generating...

Mechanical Tension in Syndecan-1 is Regulated by Extracellular Mechanical Cues and Fluidic Shear Stress

The endothelium plays a central role in regulating vascular homeostasis and is key in determining the response to materials implanted in the vascular system. Endothelial cells are uniquely sensitive to biophysical cues from applied forces and their local cellular microenvironment. The glycocalyx is a layer of proteoglycans, glycoproteins and glycosaminoglycans that lines the luminal surface of the vascular endothelium, interacting directly with the components of the blood and the forces of blood flow. In this work, we examined the changes in mechanical tension of syndecan-1, a cell surface proteoglycan that is an integral part of the glycocalyx, in response to substrate stiffness and fluidic shear stress. Our studies demonstrate that syndecan-1 is mechanically responsive to extracellular mechanical cues and alters its association with cytoskeletal and adhesion-related proteins in response to substrate stiffness and physiological flow.

Construction of a comprehensive endovascular test bed for research and device development in mechanical thrombectomy in stroke

OBJECTIVEThe development of new endovascular technologies and techniques for mechanical thrombectomy in stroke has greatly relied on benchtop simulators. This paper presents an affordable, versatile, and realistic benchtop simulation model for stroke.METHODSA test bed for embolic occlusion of cerebrovascular arteries and mechanical thrombectomy was developed with 3D-printed and commercially available cerebrovascular phantoms, a customized hydraulic system to generate physiological flow rate and pressure, and 2 types of embolus analogs (elastic and fragment-prone) capable of causing embolic occlusions under physiological flow.RESULTSThe test bed was highly versatile and allowed realistic, radiation-free mechanical thrombectomy for stroke due to large-vessel occlusion with rapid exchange of geometries and phantom types. Of the transparent cerebrovascular phantoms tested, the 3D-printed phantom was the easiest to manufacture, the glass model offered the best visibility of the interaction between embolus and thrombectomy device, and the flexible model most accurately mimicked the endovascular system during device navigation. None of the phantoms modeled branches smaller than 1 mm or perforating arteries, and none underwent realistic deformation or luminal collapse from device manipulation or vacuum. The hydraulic system created physiological flow rate and pressure leading to iatrogenic embolization during thrombectomy in all phantoms. Embolus analogs with known fabrication technique, structure, and tensile strength were introduced and consistently occluded the middle cerebral artery bifurcation under physiological flow, and their interaction with the device was accurately visualized.CONCLUSIONSThe test bed presented in this study is a low-cost, comprehensive, realistic, and versatile platform that enabled high-quality analysis of embolus–device interaction in multiple cerebrovascular phantoms and embolus analogs.